Newsweek published its annual list of the best specialized hospitals in the world, including the best oncology practices. See ...
The FDA expanded the indication for nogapendekin alfa inbakicept-pmln plus BCG to include adults with BCG-unresponsive, ...
Aetna is expanding bundled prior authorization to all cancer types, combining medical oncology, radiation oncology, and imaging into one request. Oncologists and practice staff weigh in on whether it ...
Should clinicians look for predictive biomarkers before initiating standard intravesical bacillus Calmette-Guérin (BCG) therapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC)?
On Oct. 8, the U.S. Food and Drug Administration (FDA) approved atezolizumab (Tecentriq) and atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza), each in combination with a fluoropyrimidine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results